- Home
- ZJYL vs CAPR Comparison
ZJYL vs CAPR Comparison
Compare ZJYL & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- CAPR
- Stock Information
- Founded
- ZJYL 2006
- CAPR 2005
- Country
- ZJYL China
- CAPR United States
- Employees
- ZJYL N/A
- CAPR N/A
- Industry
- ZJYL Industrial Specialties
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZJYL Consumer Discretionary
- CAPR Health Care
- Exchange
- ZJYL Nasdaq
- CAPR Nasdaq
- Market Cap
- ZJYL 320.9M
- CAPR 332.5M
- IPO Year
- ZJYL 2023
- CAPR N/A
- Fundamental
- Price
- ZJYL $1.06
- CAPR $18.62
- Analyst Decision
- ZJYL
- CAPR Strong Buy
- Analyst Count
- ZJYL 0
- CAPR 7
- Target Price
- ZJYL N/A
- CAPR $39.29
- AVG Volume (30 Days)
- ZJYL 323.8K
- CAPR 1.1M
- Earning Date
- ZJYL 07-26-2024
- CAPR 11-13-2024
- Dividend Yield
- ZJYL N/A
- CAPR N/A
- EPS Growth
- ZJYL N/A
- CAPR N/A
- EPS
- ZJYL 0.02
- CAPR N/A
- Revenue
- ZJYL $20,125,185.00
- CAPR $23,228,045.00
- Revenue This Year
- ZJYL N/A
- CAPR N/A
- Revenue Next Year
- ZJYL N/A
- CAPR $135.53
- P/E Ratio
- ZJYL $56.81
- CAPR N/A
- Revenue Growth
- ZJYL 0.75
- CAPR 65.33
- 52 Week Low
- ZJYL $0.56
- CAPR $2.90
- 52 Week High
- ZJYL $25.49
- CAPR $23.40
- Technical
- Relative Strength Index (RSI)
- ZJYL 24.53
- CAPR 51.78
- Support Level
- ZJYL $0.96
- CAPR $17.02
- Resistance Level
- ZJYL $2.20
- CAPR $20.03
- Average True Range (ATR)
- ZJYL 0.21
- CAPR 1.65
- MACD
- ZJYL -0.05
- CAPR -0.32
- Stochastic Oscillator
- ZJYL 8.06
- CAPR 51.39
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.